New Mexico Funding Priorities

Overdose prevention funding - New Mexico

There were 107,968 drug overdose deaths in the United States in 2022 (34.6 deaths per 100,000 standard population), a 1.2% increase from 2021.1

• There were 1,024 overdose deaths in New Mexico in 20222
• There were 50.3 overdose deaths per 100,000 people (age-adjusted) in New Mexico in 20222

Overdose prevention programs

• Overdose Data to Action in States
  • New Mexico Department of Health: $4,322,929

• Public Health and Public Safety
  • Overdose Response Strategy: $87,600*

*average award amount

Examples of how New Mexico is working to prevent overdose

Fentanyl education toolkit

The New Mexico Public Housing Authority coordinated with the state's Overdose Response Strategy team to pilot response teams and toolkits to combat the growing threat of illicitly manufactured fentanyl. These materials were tailored to address the unique needs and challenges of each county and included New Mexico-specific information and resources, including treatment resources, behavioral health hotlines, and fentanyl test strips.

Overdose partner collaboration tool

The New Mexico Department of Health's overdose prevention team launched a collaboration software tool to enable partners in counties and rural areas to communicate with one another directly. This tool decreases barriers to evidence-based practices and uses data-driven methods to promote professional development opportunities that build the capacity for statewide partnerships.

Increased awareness of non-opioid pain management

New Mexico supports statewide training on pain management and medications for opioid use disorder to help ensure safer prescribing and expand access to evidence-based non-opioid pain management treatment in primary care settings. The state also supports teams of certified peer support specialists in 10 emergency departments across the state to provide linkages to care to patients at risk. New Mexico also supports post-overdose responses. In this process, a pharmacist reviews the NM Prescription Monitoring Program's history of patients who experienced a nonfatal overdose, and then notifies prescribers of relevant prescriptions, offering information about screening, referral to treatment, medication management, and use of the program.